| 000 | 01258 a2200337 4500 | ||
|---|---|---|---|
| 005 | 20250513172821.0 | ||
| 264 | 0 | _c19950407 | |
| 008 | 199504s 0 0 eng d | ||
| 022 | _a0167-6296 | ||
| 024 | 7 |
_a10.1016/0167-6296(94)90010-8 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGrabowski, H G | |
| 245 | 0 | 0 |
_aReturns to R&D on new drug introductions in the 1980s. _h[electronic resource] |
| 260 |
_bJournal of health economics _cDec 1994 |
||
| 300 |
_a383-406 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aCommerce _xeconomics |
| 650 | 0 | 4 |
_aCosts and Cost Analysis _xstatistics & numerical data |
| 650 | 0 | 4 | _aData Collection |
| 650 | 0 | 4 |
_aDrug Industry _xeconomics |
| 650 | 0 | 4 |
_aDrugs, Investigational _xeconomics |
| 650 | 0 | 4 | _aHealth Policy |
| 650 | 0 | 4 |
_aIncome _xstatistics & numerical data |
| 650 | 0 | 4 |
_aResearch Support as Topic _xeconomics |
| 650 | 0 | 4 | _aUnited States |
| 650 | 0 | 4 | _aUnited States Food and Drug Administration |
| 650 | 0 | 4 | _aUnited States Office of Technology Assessment |
| 700 | 1 | _aVernon, J M | |
| 773 | 0 |
_tJournal of health economics _gvol. 13 _gno. 4 _gp. 383-406 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/0167-6296(94)90010-8 _zAvailable from publisher's website |
| 999 |
_c10100099 _d10100099 |
||